[Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)]
- PMID: 7200547
- DOI: 10.1007/BF01728344
[Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)]
Abstract
Concentrations of platin were determined with the method of atomic absorption spectroscopy in plasma and urine from the 1st until 28th day after cis-DDP (3 mg/kg) infusion for 1, 8, and 24 h. Maximum of plasma concentration was measured always at the end of the application time. Minimal concentration was 1.9 micrograms/ml, maximal concentration 5.8 micrograms/ml. Platin could be detected until the 21st respectively 28th day between 0.01 and 0.9 micrograms/ml. The duration of cis-DDP infusions was without influence on the mean excretion of platin. Between 24 and 25% of the infused platin was excreted after 24 h, between 4.8 and 7% after further 24 h, between 1 and 2% between the 3rd and 21st day, and less than 1% thereafter. Difference in pattern of toxicity could not be clearly detected.
Similar articles
-
[The iodine 131-hippurate clearance for the determination of the nephrotoxic effect of cis-dichlorodiamino-platin (II) (cis-platin, cis-DDP)].Klin Wochenschr. 1983 Jun 1;61(11):561-6. doi: 10.1007/BF01486846. Klin Wochenschr. 1983. PMID: 6683771 German.
-
Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.Br J Clin Pharmacol. 1991 Aug;32(2):173-9. doi: 10.1111/j.1365-2125.1991.tb03878.x. Br J Clin Pharmacol. 1991. PMID: 1931468 Free PMC article.
-
Cis-platinum in the treatment of testicular and other cancers.Adv Intern Med. 1982;27:531-45. Adv Intern Med. 1982. PMID: 7041553 Review. No abstract available.
-
Kinetics of cis-dichlorodiammineplatinum.Clin Pharmacol Ther. 1979 Mar;25(3):351-7. doi: 10.1002/cpt1979253351. Clin Pharmacol Ther. 1979. PMID: 761445
-
[Cis-diamminedichloroplatinum(II). A new antineoplastic agent derived from the group of heavy metal complexes (author's transl)].Klin Wochenschr. 1979 Dec 3;57(23):1249-58. doi: 10.1007/BF01492980. Klin Wochenschr. 1979. PMID: 121143 Review. German.
Cited by
-
Influence of infusion time on unchanged cisplatin disposition in patients with ovarian cancer.Cancer Chemother Pharmacol. 1989;24(4):256-60. doi: 10.1007/BF00257629. Cancer Chemother Pharmacol. 1989. PMID: 2752507